Nódulos tiroideos

1. Vander JB, Gaston EA, Dawber TR. 1968. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann. Intern.Med. 69:537–40

2. Tunbridge WM, Evered DC, Hall R, et al. 1977. The spectrum of thyroid disease in a community: theWhickham survey. Clin. Endocrinol. 7:481–93

3. Mortensen JD, Woolner LB, Bennett WA. 1955. Gross and microscopic findings in clinically normalthyroid glands. J. Clin. Endocrinol. Metab. 15:1270–80

4. Ezzat S, Sarti DA, Cain DR, Braunstein GD. 1994. Thyroid incidentalomas. Prevalence by palpation andultrasonography. Arch. Intern. Med. 154:1838–40

5. Dean DS, Gharib H. 2008. Epidemiology of thyroid nodules. Best Pract. Res. Clin. Endocrinol. Metab.22:901–11

6. Mazzaferri EL. 1993. Management of a solitary thyroid nodule. N. Engl. J.Med. 328:553–59 7. Hegedüs L. 2004. Clinical practice. The thyroid nodule. N. Engl. J.Med. 351:1764–71

8. Sherman SI. 2003. Thyroid carcinoma. Lancet 361:501–11

9. Sosa JA,Hanna JW,Robinson KA,Lanman RB. 2013. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery 154:1420–26

10. Natl. Cancer Inst. 2021. Cancer Stat Facts: Thyroid Cancer. Natl. Cancer Inst. Surveill. Epidemiol. End Results Program. https://seer.cancer.gov/statfacts/html/thyro.html. Accessed Mar. 30, 2021

11. Davies L,Welch HG. 2014. Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg. 140:317–22

12. Li M, Dal Maso L, Vaccarella S. 2020. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 8:468–70

13. Haugen BR, Alexander EK, Bible KC, et al. 2016. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133

14. Klubo-Gwiezdzinska J, Yang L, Merkel R, et al. 2017. Results of screening in familial non-medullarythyroid cancer. Thyroid 27:1017–24

15. Am. Inst. Ultrasound Med. 2014. AIUM practice guideline for the performance of ultrasound examinations of the head and neck. J. Ultrasound.Med. 33:366–82

16. Soelberg KK, Bonnema SJ, Brix TH, Hegedus L. 2012. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22:918– 25

17. Trimboli P, Paone G, Treglia G, et al. 2018. Fine-needle aspiration in all thyroid incidentalomas at 18FFDG PET/CT: Can EU-TIRADS revise the dogma? Clin. Endocrinol. 89:642–48

18. Tessler FN,Middleton WD, Grant EG, et al. 2017. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J. Am. Coll. Radiol. 14:587–95

19. Moon WJ, Jung SL, Lee JH, et al. 2008. Benign and malignant thyroid nodules: US differentiation–multicenter retrospective study. Radiology 247:762–70

20. Lee JH, Han K, Kim EK, et al. 2017. Validation of the modified 4-tiered categorization system through comparison with the 5-tiered categorization system of the 2015 American Thyroid Association guidelines for classifying small thyroid nodules on ultrasound. Head Neck 39:2208–15

21. Kim EK, Park CS, Chung WY, et al. 2002. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am. J. Roentgenol. 178:687–91

22. Remonti LR, Kramer CK, Leitao CB, et al. 2015. Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid 25:538–50

23. Campanella P, Ianni F, Rota CA, et al. 2014. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur. J. Endocrinol. 170:R203–11

24. Na DG, Baek JH, Sung JY, et al. 2016. Thyroid imaging reporting and data system risk stratification of thyroid nodules: categorization based on solidity and echogenicity. Thyroid 26:562–72

25. Gwon HY, Na DG, Noh BJ, et al. 2020. Thyroid nodules with isolated macrocalcifications: malignancy risk of isolated macrocalcifications and postoperative risk stratification of malignant tumors manifesting as isolated macrocalcifications. Korean J. Radiol. 21:605–13

26. Moon HJ, Kwak JY, Kim MJ, et al. 2010. Can vascularity at power Doppler US help predict thyroid malignancy? Radiology 255:260–69

27. Slowinska-Klencka D, Wysocka-Konieczna K, Klencki M, Popowicz B. 2020. Diagnostic value of six thyroid imaging reporting and data systems (TIRADS) in cytologically equivocal thyroid nodules. J. Clin. Med. 9:2281

28. Castellana M, Castellana C, Treglia G, et al. 2020. Performance of five ultrasound risk stratification systems in selecting thyroid nodules for FNA. J. Clin. Endocrinol. Metab. 105:1659–69

29. Huh S, Lee HS, Yoon J, et al. 2020. Diagnostic performances and unnecessary US-FNA rates of various TIRADS after application of equal size thresholds. Sci. Rep. 10:10632